AKASA

akasa.com

HQ: South San Francisco, California, United States

200

Healthcare

Company research

Public company, workplace, funding, and market signals

Updated Aug 16, 2026

Overview

AKASA is a healthcare technology company providing generative-AI automation for hospital revenue-cycle management. Its platform helps health systems automate and improve workflows spanning prior authorization, clinical documentation integrity, medical coding, claims status, and denials.

Primary product

AKASA Platform, including AI-powered solutions such as Coding Optimizer, CDI Optimizer, Authorization Advisor, Claims Status, and AI Advisor.

Founded

2019

Headquarters

South San Francisco, California, United States

Team size

100-150

Industry

Healthcare technology

Sub-industry

Healthcare revenue-cycle management and generative AI

Offices

South San Francisco, California, United States

Business model

Enterprise SaaS

B2B healthcare software

Usage- and outcome-oriented healthcare automation

Funding

Stage

Late-stage venture / Series C

Total raised

$205M

Latest round

Series C · Jun 2024

Latest amount

$120M

Series C

Jun 2024

$120M

Series B

Mar 2021 · BOND

$60M

Series A

Jun 2020

$20M

Seed

Jan 2019

$5M

People & investors

Leadership

Malinka Walaliyadde

CEO and Co-founder

Varun Ganapathi

Co-founder and CTO

Andy Atwal

Co-founder and VP, Engineering

Benjamin Beadle-Ryby

Co-founder

Cory Costley

Chief Product Officer

Sanjay Siddhanti

Chief Technology Officer

Zach Barrett

Chief Operating Officer

Nirav Kamdar

Vice President, Clinical Strategy

Investors

Andreessen Horowitz

BOND

Costanoa Ventures

Work & culture

Public company materials emphasize a mission-driven, collaborative approach to reducing healthcare financial complexity; investment in high-caliber talent; customer-centric product development; and using AI to augment revenue-cycle employees rather than simply replace them. Specific current workplace policies and benefits are not sufficiently disclosed in the researched sources.

Compensation

Third-party company data reports example annual compensation signals of approximately $74,801 for a Revenue Cycle Analyst and $96,471 for a Customer Success Manager. These are not official company-wide ranges and should be treated as directional only.

Product & market

Pricing

Not publicly disclosed; appears to be enterprise software sold through customized health-system contracts rather than self-serve pricing.

Differentiators

—Health-system-specific custom LLMs trained on each customer’s clinical and financial data
—Combines deep revenue-cycle expertise with generative AI rather than offering a general-purpose AI layer
—Broad platform coverage across financial clearance, prior authorization, CDI, coding, claims, and denials
—Designed to surface clinical evidence and maintain auditable support for coding and claims decisions
—Reported customer outcomes include faster document review, reduced staff workload, additional revenue capture, and improved quality indicators
—AKASA states that its customer base represents more than 650 hospitals and 6,500 outpatient facilities across all 50 states

Technology

Generative AI

Custom large language models trained on health-system clinical and financial data

Machine learning

Healthcare revenue-cycle automation

EHR and revenue-cycle-system integrations

API integration and web-based healthcare data acquisition

Healthcare compliance and security controls

OpenAI and Hugging Face are reported by third-party technology directories, but the exact production use is not publicly confirmed

Customers

Cleveland Clinic

Duke University Health System

Methodist Health System

Montage Health

Hospitals and health systems across the United States

Competitors

R1 RCM

CodaMetrix

Nym

Infinx

SmarterDx

AKASA’s broader competitors include healthcare revenue-cycle automation, autonomous coding, CDI, claims-management, and prior-authorization vendors

Scale & contact

Estimated revenue

$1 million-$10 million annually; one third-party estimate reports approximately $7 million

Estimated monthly visits

18K

Traffic estimate as of Jun 2026

Signals & risks

Other

Mar 2025

A former AKASA software engineer publicly stated on LinkedIn that they were affected by recent reductions impacting their team. The scope and exact number of affected employees were not publicly disclosed.

Source

Other

Public employee-growth data indicates the company continued hiring and reported approximately 123 employees, but job-posting and workforce data is third-party and may lag actual staffing changes.

Source

Latest news

80% of health systems moving forward on AI for revenue cycle: survey

Fierce Healthcare · Dec 2025

Coverage of an HFMA and AKASA survey reported that 80% of health systems were exploring, piloting, or implementing generative AI for revenue-cycle management in 2025, up from 58% in 2023.

Cleveland Clinic and AKASA expand partnership to deploy AI coding and CDI tools across U.S. locations

AKASA · Oct 2025

Cleveland Clinic expanded its AKASA relationship after rolling out AKASA’s AI coding tool across its U.S. locations, adding a clinical documentation integrity solution. AKASA described the deployment as a major real-world use of generative AI in healthcare finance.

Generative AI delivers new revenue-cycle value for Cleveland Clinic

Becker's Hospital Review · Aug 2025

Cleveland Clinic and AKASA leaders reported early deployment results, including missed diagnosis-coding opportunities identified in approximately 15% of inpatient cases reviewed and acceptance of about half of those recommendations by human coders.

Cleveland Clinic and AKASA announce strategic collaboration to launch AI revenue-cycle tools

Cleveland Clinic Newsroom · Apr 2025

The organizations announced a collaboration covering AI-assisted medical coding and a CDI pilot. Cleveland Clinic said the tools could read clinical documents in less than two seconds and process more than 100 documents in 1.5 minutes.

AKASA raises $120 million in latest funding round

Signalbase · Jul 2024

Third-party funding coverage reported that AKASA raised $120 million in a Series C financing, bringing total reported funding above $200 million. The financing was intended to expand the AI platform and healthcare revenue-cycle offering.

Jobs and careers at AKASA

11 jobs at AKASA

Associate Director, Customer Engagement

Remote

Deployment Customer Engagement

South San Francisco; South San Francisco, California, United States

2w ago

Remote

Full-time